Top Medical News from Across Medscape

  • Artificial Sweeteners Alter Gut Response to GlucoseLarge amounts of artificial sweeteners interfere with the gut's response to glucose, increasing both glucose absorption and glycemic response and inhibiting production of GLP-1.
  • In Breast Cancer, a Victory for Common SenseAn ambitious randomized clinical trial neither accrued its planned number of patients nor met its expected events but has changed cancer care anyway
  • 'MAP' Program Improves Hypertension ControlThe MAP program focuses on an accurate BP, intensifying treatment when an elevated BP is confirmed, and partnering with the patient to select and carry out the treatment plan.

Special Report

  • Healthcare policy is the number one topic -- not just in Washington, DC but in hospitals, medical practices, and homes. With so much happening on so many fronts, it's hard to keep up. Let us do it for you.

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California